Prothena Corporation plc - Ordinary Shares (PRTA) Social Stream
PROTHENA CORP PUBLIC LTD CO (PRTA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PROTHENA CORP PUBLIC LTD CO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 9 | $103 | $29 | $76.5 | $33.19 | 130.49% |
| 2022-01-13 | 9 | $103 | $29 | $76.555 | $33.19 | 130.66% |
| 2022-01-20 | 9 | $100 | $29 | $73.555 | $33.19 | 121.62% |
| 2022-01-26 | 9 | $100 | $29 | $71.111 | $33.19 | 114.25% |
| 2022-02-02 | 7 | $100 | $54 | $76.375 | $33.19 | 130.11% |
| 2022-02-17 | 8 | $100 | $54 | $76.375 | $33.19 | 130.11% |
| 2022-02-18 | 8 | $100 | $52 | $76.125 | $33.19 | 129.36% |
| 2022-05-10 | 7 | $100 | $47 | $75.5 | $33.19 | 127.48% |
| 2022-05-25 | 7 | $100 | $47 | $72.125 | $33.19 | 117.31% |
| 2022-08-13 | 6 | $100 | $47 | $72.142 | $33.19 | 117.36% |
| 2022-09-17 | 6 | $100 | $45 | $71.857 | $33.19 | 116.5% |
| 2022-09-29 | 7 | $110 | $47 | $73.714 | $33.19 | 122.1% |
| 2022-10-16 | 7 | $110 | $52 | $79.857 | $33.19 | 140.61% |
| 2022-10-24 | 8 | $110 | $52 | $78.75 | $33.19 | 137.27% |
| 2022-11-04 | 8 | $110 | $55 | $79.125 | $33.19 | 138.4% |
| 2022-11-11 | 8 | $110 | $55 | $79 | $33.19 | 138.02% |
| 2022-12-02 | 8 | $120 | $55 | $82.125 | $33.19 | 147.44% |
| 2022-12-05 | 8 | $120 | $55 | $84.125 | $33.19 | 153.46% |
| 2022-12-21 | 8 | $120 | $55 | $85 | $33.19 | 156.1% |
| 2023-01-27 | 9 | $120 | $55 | $85 | $33.19 | 156.1% |
| 2023-02-08 | 8 | $120 | $55 | $86 | $33.19 | 159.11% |
| 2023-02-24 | 9 | $120 | $55 | $86 | $33.19 | 159.11% |
| 2023-02-27 | 9 | $120 | $55 | $86.111 | $33.19 | 159.45% |
| 2023-05-04 | 10 | $120 | $55 | $85.5 | $33.19 | 157.61% |
| 2023-05-05 | 10 | $120 | $55 | $87.5 | $33.19 | 163.63% |
| 2023-05-08 | 10 | $120 | $55 | $89.7 | $33.19 | 170.26% |
| 2023-06-06 | 10 | $120 | $60 | $90.3 | $33.19 | 172.07% |
| 2023-08-04 | 10 | $129 | $60 | $91.2 | $33.19 | 174.78% |
| 2023-08-07 | 10 | $129 | $60 | $91.3 | $33.19 | 175.08% |
| 2023-10-25 | 9 | $129 | $60 | $93.444 | $33.19 | 181.54% |
| 2023-11-02 | 9 | $129 | $60 | $91.777 | $33.19 | 176.52% |
| 2023-11-06 | 9 | $129 | $43 | $89.888 | $33.19 | 170.83% |
| 2023-11-13 | 9 | $129 | $43 | $89.444 | $33.19 | 169.49% |
The Trend in the Analyst Price Target
PRTA's average price target has moved up $17.3 over the prior 15 months.
PRTA reports an average of 65.1% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-02 | 8 | 120 | 55 | 82.125 | 65.00 | 26.35% |
| 2023-02-01 | 9 | 120 | 55 | 86.000 | 53.67 | 60.24% |
| 2023-02-08 | 8 | 120 | 55 | 86.000 | 55.32 | 55.46% |
| 2023-05-05 | 10 | 120 | 55 | 87.500 | 78.59 | 11.34% |
| 2023-11-06 | 9 | 129 | 43 | 89.888 | 35.73 | 151.58% |
PRTA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.22 | 8 | 0 | 1 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
PRTA's average broker recommendation rating improved by 0.16 over the prior 24 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PROTHENA CORP PUBLIC LTD CO's upside potential (average analyst target price relative to current price) is higher than 3402.53% of all US stocks.
- In terms of how PROTHENA CORP PUBLIC LTD CO fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3235.81% of that group.
- In terms of how PROTHENA CORP PUBLIC LTD CO fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 3435.55% of that group.
- In terms of how PROTHENA CORP PUBLIC LTD CO fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 2366.33% of that group.
In the Pharmaceutical Products industry, IRWD, AGIO, and ESPR are the three stocks most similar to PROTHENA CORP PUBLIC LTD CO regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PRTA? Use POWR Ratings for clearer insight into price direction.